US HB1384 | 2021-2022 | 117th Congress
Status
Spectrum: Moderate Partisan Bill (Democrat 204-47)
Status: Introduced on February 25 2021 - 25% progression, died in committee
Action: 2021-04-28 - Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Pending: House Subcommittee on Crime, Terrorism, and Homeland Security Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 25 2021 - 25% progression, died in committee
Action: 2021-04-28 - Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Pending: House Subcommittee on Crime, Terrorism, and Homeland Security Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) to eliminate the separate registration requirement for dispensing narcotic drugs in schedule III, IV, or V (such as buprenorphine) for maintenance or detoxification treatment, and for other purposes.
Title
Mainstreaming Addiction Treatment Act of 2021
Sponsors
History
Date | Chamber | Action |
---|---|---|
2021-04-28 | House | Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. |
2021-02-25 | House | Referred to the Subcommittee on Health. |
2021-02-25 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2021-02-25 | House | Introduced in House |
Same As/Similar To
SB445 (Related) 2021-02-25 - Referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/117th-congress/house-bill/1384/all-info |
Text | https://www.congress.gov/117/bills/hr1384/BILLS-117hr1384ih.pdf |